These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22493613)

  • 1. The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy.
    Kwon HW; Kwon BS; Kim GB; Chae JH; Park JD; Bae EJ; Noh CI
    Korean Circ J; 2012 Mar; 42(3):184-91. PubMed ID: 22493613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.
    Kajimoto H; Ishigaki K; Okumura K; Tomimatsu H; Nakazawa M; Saito K; Osawa M; Nakanishi T
    Circ J; 2006 Aug; 70(8):991-4. PubMed ID: 16864930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
    Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
    Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.
    Connuck DM; Sleeper LA; Colan SD; Cox GF; Towbin JA; Lowe AM; Wilkinson JD; Orav EJ; Cuniberti L; Salbert BA; Lipshultz SE;
    Am Heart J; 2008 Jun; 155(6):998-1005. PubMed ID: 18513510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
    Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
    Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
    J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac involvement in Fukuyama-type congenital muscular dystrophy.
    Nakanishi T; Sakauchi M; Kaneda Y; Tomimatsu H; Saito K; Nakazawa M; Osawa M
    Pediatrics; 2006 Jun; 117(6):e1187-92. PubMed ID: 16717122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical cardiomyopathy in Becker muscular dystrophy.
    Steare SE; Dubowitz V; Benatar A
    Br Heart J; 1992 Sep; 68(3):304-8. PubMed ID: 1389764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
    Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precordial R wave height does not correlate with echocardiographic findings in boys with Duchenne muscular dystrophy.
    Thrush PT; Edward N; Flanigan KM; Mendell JR; Allen HD
    Congenit Heart Dis; 2013; 8(6):561-7. PubMed ID: 23510265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major.
    Karvounis HI; Zaglavara TA; Parharidis GE; Nouskas IG; Hassapopoulou EP; Gemitzis KD; Louridas GE
    Am Heart J; 2001 Feb; 141(2):281. PubMed ID: 11174351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
    Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Early Left Ventricular Dysfunction in Patients with Duchenne Muscular Dystrophy Using Two-Dimensional Speckle Tracking Echocardiography and Tissue Doppler Imaging.
    Cho MJ; Lee JW; Lee J; Shin YB
    Pediatr Cardiol; 2018 Dec; 39(8):1614-1619. PubMed ID: 30003298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
    Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of catheter ablation of idiopathic ventricular ectopic beats on left ventricular function and exercise capacity.
    Lelakowski J; Dreher A; Majewski J; Bednarek J
    Kardiol Pol; 2009 Aug; 67(8):847-55. PubMed ID: 19784882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.